Product Information
IPRATROPIUM 0.06% SPRAY is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.7775 per ML under NDC 00054004641. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Nov 5, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
42 ug/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054004641
Classification
Generic
Dosage Form
SPRAY
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
IPRATROPIUM BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076598FDA Approved
11/5/2003
TE Code
AB
On Market Since
11/5/2003
Pharmacological Classes
Price Statistics
The NADAC for IPRATROPIUM 0.06% SPRAY has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 40.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7775 per ML |
|---|---|
| All-time high | $1.7777 (Dec 16, 2020) |
| All-time low | $0.7775 (Sep 23, 2026) |
| 52-week high | $1.0672 |
| 52-week low | $0.7775 |
| Median price | $1.4087 |
| Average price | $1.3855 |
| Largest weekly change | -20.7% (Apr 17, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ipratropium Bromide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IPRATROPIUM 0.06% SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for IPRATROPIUM 0.06% SPRAY, manufactured by Hikma Pharmaceuticals USA Inc., is $0.7775 per ML (NDC 00054004641), effective Sep 30, 2026.
How has the price of IPRATROPIUM 0.06% SPRAY changed over time?
Over the history we have for it, the NADAC for IPRATROPIUM 0.06% SPRAY has declined 40.3%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for IPRATROPIUM 0.06% SPRAY?
Since Nov 28, 2013, the NADAC for IPRATROPIUM 0.06% SPRAY has ranged from a low of $0.7775 (Sep 23, 2026) to a high of $1.7777 (Dec 16, 2020), with a median of $1.4087 per ML.
Are there cheaper alternatives to IPRATROPIUM 0.06% SPRAY?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IPRATROPIUM 0.06% SPRAY in a comparable dosage form, but none are currently priced below it.
Who manufactures IPRATROPIUM 0.06% SPRAY?
IPRATROPIUM 0.06% SPRAY (NDC 00054004641) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.